中文 | English
Return
Total: 252 , 1/26
Show Home Prev Next End page: GO
MeSH:(Half-Life*)

1.Suggestions for Radiopharmaceutical Drug Development in Korea Focusing on FDA Exploratory IND Guideline.

Young Hoon RYU ; Tae Hyun CHOI

Nuclear Medicine and Molecular Imaging 2007;41(6):525-529

2.Pharmacodynamic principles and the time course of immediate drug effects.

Nick HOLFORD

Translational and Clinical Pharmacology 2017;25(4):157-161

3.High Dose Rate Ir-192 Source Calibration Method with Newly Designed Calibration Jig.

Byong Yong YI ; Eun Kyung CHOI ; Hyesook CHANG

Journal of the Korean Society for Therapeutic Radiology 1989;7(2):299-304

4.How to design intravenous anesthetic dose regimens based on pharmacokinetics and pharmacodynamics principles.

Jong Cook PARK

Anesthesia and Pain Medicine 2015;10(4):235-244

5.Effects of CYP1A enzyme specific inhibitor on pharmacokinetics of para-acetaminophen in Bactrian camel

Ren SAN ; Weidong YUE ; Surong HASI

Journal of Veterinary Science 2019;20(3):e12-

6.Impact Factors and Publication Times of Korean Plastic Surgery Journals.

Kun HWANG ; Hyuk Kyu CHOI

Journal of the Korean Society of Plastic and Reconstructive Surgeons 2008;35(2):147-151

7.Clearance.

Nick HOLFORD ; Dong Seok YIM

Translational and Clinical Pharmacology 2015;23(2):42-45

8.Absorption and Half-Life.

Nick HOLFORD

Translational and Clinical Pharmacology 2016;24(4):157-160

9.Lidoeaine Pharmaeokinetics in Patients with End-Stage Renal Diaease during Anesthesia.

Won Oak KIM ; Jong Suk LEE ; Yang Sik SHIN ; Jong Rae KIM ; Kwang Won PARK

Korean Journal of Anesthesiology 1987;20(6):762-767

10.Oral Riboflavine Tetrabutyrate Therapy for Psoriasis.

Chan Jong KEY ; Chang Jo KOH ; Baik Kee CHO

Korean Journal of Dermatology 1979;17(2):117-121

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 252 , 1/26 Show Home Prev Next End page: GO